Cleveland BioLabs Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
20,129.30
35.40
13,044.90
2,590.10
9,842.70
3,707.40
Depreciation, Depletion & Amortization
471.20
841.00
140.10
63.50
21.10
18.20
Other Funds
-
5,152.40
-
-
-
1,029.50
Funds from Operations
20,788.80
15,014.70
10,638.70
5,793.80
5,456.70
4,718.70
Changes in Working Capital
2,313.90
559.50
1,441.40
754.10
1,154.70
105.30
Net Operating Cash Flow
23,102.60
14,455.20
12,080.10
5,039.60
6,611.50
4,613.40
Capital Expenditures
139.50
20.20
-
10.20
4.40
Sale of Fixed Assets & Businesses
-
-
3,005.90
198.90
9.00
Purchase/Sale of Investments
2,197.90
281.50
13,282.50
5,484.30
3,883.30
Net Investing Cash Flow
560.70
1,786.70
10,276.60
5,673.00
3,887.90
Issuance/Reduction of Debt, Net
7,249.60
4,259.90
2,672.20
-
-
Net Financing Cash Flow
7,261.90
10,590.00
24,935.60
540.00
-
Net Change in Cash
15,603.60
6,944.50
2,814.50
983.40
2,671.30
Free Cash Flow
23,242.10
14,475.40
-
5,049.90
6,615.90
Change in Capital Stock
12.40
9,697.50
27,607.80
540.00
-
Exchange Rate Effect
323.60
1,292.60
235.60
190.00
52.30
Other Uses
1,497.70
2,048.00
-
-
-
About Cleveland BioLabs
View Profile
